In glioma, we observed a protein enrichment of damage-associated molecular pattern (DAMP) molecules, including HMGB1 and HMGB2, which interact with pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs)18 (Fig. 4c). This evidence concerns the gene HMGB2 and central nervous system cancer.